Applicability of an arm exoskeleton for persons with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy

Completed

• Conditions: DMD / Spinal Musclular Atrophy; Duchenne Muscular Dystrophy; SMA; 10029299; 10029317

• Registration Number: NL-OMON45622
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 26

Inclusion Criteria

DNA established diagnosis of DMD or SMA
Brooke scale 1 to 4
Ambuland and non-ambulant

Exclusion Criteria

Participants younger than 7 years
Other disabling diseases influencing upper extremity function

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The most important outcome measures are: maximal muscle force, active range of<br /><br>motion, muscle activity measured with surface electromyography and trunk<br /><br>impairment score.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary outcome measures are: passieve range of motion, trunk balance and<br /><br>stability, performance of upper limb scale, 9-hole peg test, Timed_TIHM en<br /><br>Brooke scale. </p><br>